TAMPA, Fla.—As reported by EurekAlert, researchers affiliated with Natura Therapeutics, Inc. and the University of South Florida (USF) received a one-year, $110,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health's (NIH) National Center for Complementary and Alternative Medicine to continue studying whether TeaMem™, a compound made from green tea, may help prevent and treat Alzheimer's disease (AD).
The grant will be used to investigate the role of TeaMem in opposition to cleavage of the amyloid precursor protein protelysis (APP) into Abeta peptides and resultant cerebral amyloidosis, a process identified as a key feature in AD’s pathology.
"Our recent findings suggest that strategies that promote non-amyloidogenic/alpha-secretase APP processing may have significant potential for the treatment of AD," said one researcher.